HOSPITAL STOCKS; The national drug price regulator on Wednesday revised the maximum retail prices of as many as 543 cancer drugs brands, slashing some of them by more than 90%.

The new prices will take effect on November 9, following the NPPA's decision to cap trade margins at 30% of MRP for 137 non-scheduled anti-cancer drugs.

S D RETAIL LIMITED

← Back to feed